EQT to acquire majority stake in European pharma company Adalvo from Aztiq
LONDON: Aztiq has agreed to sell its majority stake in Adalvo to global investment firm EQT, expanding EQT’s portfolio in the pharmaceutical sector across Europe, Asia Pacific and the Americas. Founded by Aztiq in 2018, Adalvo has grown into a leading business-to-business pharmaceutical company, employing more than 280 staff and maintaining over 170 commercial partnerships…